F-18 FDG PET/CT imaging of primary hepatic neuroendocrine tumor

18F-FDG PET/CT Imaging of Primary Hepatic Neuroendocrine Tumor

Primary hepatic neuroendocrine tumors (PHNETs) are extremely rare neoplasms. Herein, we report a case of a 70- year-old man with a hepatic mass. The non-contrast computed tomography (CT) image showed a low-density mass, and dynamic CT images indicated the enhancement of the mass in the arterial phase and early washout in the late phase. F-18 fluorodeoxyglucose ((18)F-FDG) positron emission tomo...

F 18 FDG PETCT detection for liver metastases

Reduced-dose [F]-FDG PETCT scanning with current generation PETCT systems

[ 18 F ] Fdg - Pet

Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.

UNLABELLED Nuclear medicine plays an important role in the imaging of neuroendocrine tumors (NETs). Somatostatin receptor scintigraphy (SRS) with (111)In-labeled somatostatin receptor analogs is a standard procedure for the detection and staging of NET. Based on the ability of NETs to store biogenic amines, this study evaluated whether 6-(18)F-fluoro-L-DOPA ((18)F-FDOPA) is a suitable PET trace...

Society of Nuclear Medicine Procedure Guideline for Tumor Imaging Using F-18 FDG

There is a growing body of evidence for the use of FDG in the differentiation of malignant from benign disease, staging and grading of malignant disease, differentiating recurrent or residual disease from therapy induced changes, and monitoring the response to therapy. Depending on the clinical question and type of equipment available, the FDG imaging procedure may include: A. Limited Field Tom...